Nxera Pharma Co., Ltd. (TYO: 4565)
Japan flag Japan · Delayed Price · Currency is JPY
1,137.00
+17.00 (1.52%)
Nov 21, 2024, 3:45 PM JST

Nxera Pharma Revenue

Nxera Pharma had revenue of 9.26B JPY in the quarter ending September 30, 2024, with 178.34% growth. This brings the company's revenue in the last twelve months to 29.28B, up 136.05% year-over-year. In the year 2023, Nxera Pharma had annual revenue of 12.77B, down -18.00%.

Revenue (ttm)
29.28B
Revenue Growth
+136.05%
P/S Ratio
3.42
Revenue / Employee
78.70M
Employees
350
Market Cap
102.22B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202312.77B-2.80B-18.00%
Dec 31, 202215.57B-2.14B-12.10%
Dec 31, 202117.71B8.87B100.32%
Dec 31, 20208.84B-884.00M-9.09%
Dec 31, 20199.73B6.18B173.97%
Dec 31, 2018 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro